ABSTRACT & COMMENTARY

CABG Wins Again for Multivessel Disease

Name: Relias Media
Price range: $

March 30, 2022

Fractional flow reserve-guided percutaneous coronary intervention failed to meet noninferiority guidelines vs. coronary artery bypass grafting.

Issue Date: March 30, 2022

Table of Contents

Financial Disclosure: Dr. Stephen Brunton, physician editor, reports he is on the speakers bureau for AstraZeneca, Bayer, Boehringer Ingelheim, Eli Lilly, and Novo Nordisk; and is a retained consultant for Abbott Diabetes Care, AstraZeneca, Bayer, GSK, and Novo Nordisk. The relevant financial relationships listed have been mitigated. None of the remaining planners or authors for this educational activity have relevant financial relationships to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Subscription Publication Books & Study Guides Group & Site Licenses State CME/CE Requirements